Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...

Clinical Trial ID NCT01118091

PubWeight™ 4.26‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01118091

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer statistics, 2007. CA Cancer J Clin 2007 53.49
2 High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am 2000 4.19
3 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
4 Trial Watch: Adoptive cell transfer immunotherapy. Oncoimmunology 2012 1.18
5 Management of pediatric mild traumatic brain injury: a neuropsychological review from injury through recovery. Clin Neuropsychol 2007 1.15
6 Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology 2013 0.95
7 Focus on adoptive T cell transfer trials in melanoma. Clin Dev Immunol 2010 0.81
Next 100